title: [Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
authors.affiliation: Médecin nucléaire, Centre Eugène-Marquis, Rennes.
authors.forename: P
authors.initials: P
authors.lastname: Bourguet
authors.forename: A
authors.initials: A
authors.lastname: Hitzel
authors.forename: G
authors.initials: G
authors.lastname: Houvenaeghel
authors.forename: D
authors.initials: D
authors.lastname: Vinatier
authors.forename: L
authors.initials: L
authors.lastname: Bosquet
authors.forename: F
authors.initials: F
authors.lastname: Bonichon
authors.forename: C
authors.initials: C
authors.lastname: Corone
authors.forename: S
authors.initials: S
authors.lastname: Giard-Lefèvre
authors.forename: J-L
authors.initials: JL
authors.lastname: Morett
authors.forename: E
authors.initials: E
authors.lastname: Touboul
mesh_terms: D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000592:standards*; D019275:Radiopharmaceuticals; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18